To encourage precision medicine adoption, a different approach to physician education is required. This webinar will demonstrate how data and omnichannel strategies can enhance engagement by precisely targeting physicians treating patients with relevant biomarkers.
In this webinar, attendees will explore how leveraging laboratory data can drastically accelerate the adoption of novel treatments, enabling rapid engagement with physicians within 24 h after a patient tests positive for a relevant biomarker. The speaker will delve into strategies for cutting through the noise of a highly saturated digital environment to effectively reach and engage physicians.
She will showcase recent methods that use prospective diagnostics data to reach physicians exactly when they make treatment recommendations. Moreover, she will explore how integrating real-world data can improve the accuracy of a patient and their provider identification, ensuring that the right message reaches the right physician.
The webinar will also provide a practical walkthrough of successful digital engagement strategies, illustrating an omnichannel approach that utilizes lab data to boost the adoption of biomarkers and therapies. Attendees will also learn why commercial success in precision medicine necessitates a distinct approach to clinical education, focusing on targeted and timely interactions with healthcare providers.
Additionally, the speaker will discuss real-world examples of educational campaigns and examine metrics that have effectively measured return on investment in these contexts. Attendees will learn how prospective diagnostics data can be harnessed and how educational strategies can be implemented to drive the adoption of innovative treatments and maximize commercial success in precision medicine.
Join this webinar to discover how leveraging data can enhance physician engagement, optimize testing and treatment recommendations and ultimately drive the adoption of precision medicine.
Speaker
Gosia Leitch, VP of Engagement Solutions, Diaceutics
Gosia Leitch is the Vice President of Engagement Solutions at Diaceutics, where she leverages over 20 years of experience in the diagnostics and pharmaceutical industries to drive impactful engagement strategies for clients. Specializing in brand management, strategy, commercial marketing and sales management, Gosia plays a crucial role in helping global leaders develop and implement effective commercialization strategies for precision medicines.
Before joining Diaceutics, Gosia held senior roles in global commercial marketing where she successfully led initiatives that enhanced brand visibility and market penetration. Her strategic vision and expertise have been instrumental in fostering innovation and ensuring the successful launch of precision medicine solutions.
Read more...
Read Less...
Who Should Attend?
This webinar will appeal to professionals with the following titles or those involved in market segmentation, maximizing therapy adoption and provider engagement:
- Head of Global Business/Market Analytics/Precision Medicine
- Advanced Analytics
- Director, Commercial Insights and Operations
- US Commercial Head/Lead
- Vice President, Precision Medicine/Clinical Trial Strategy & Operations
- Vice President, Insights & Analytics
- Healthcare Professional (HCP) Marketing/Marketing and Market Access teams
- Pharmaceutical Sales
What You Will Learn
Attendees will gain insights into:
- Why precision medicine commercial success requires a different approach to clinical education
- How data driven omnichannel allows very precise targeting and timing of engagement
- How prospective diagnostics data can be utilized to reach physicians at the right time when they make treatment recommendations
- How to design omnichannel education to accelerate novel biomarker and treatment adoption
- Examples of educational campaigns and metrics that have been used to track ROI
Xtalks Partner
Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharmaceutical and life science companies with solutions and technology for the commercialisation of their precision medicines, enabled by the proprietary DXRX platform.
DXRX is the world’s first diagnostic commercialisation platform for precision medicine, utilising a global network of affiliate laboratories to deliver multiple pipelines of real-world healthcare data insights, advisory services and innovative platform-enabled solutions.
Related Webinars
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account